These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9700430)

  • 1. Preliminary experience of the DIAS computer model in providing insulin dose advice to patients with insulin dependent diabetes.
    Cavan DA; Hejlesen OK; Hovorka R; Evans JA; Metcalfe JA; Cavan ML; Halim M; Andreassen S; Carson ER; Sönksen PH
    Comput Methods Programs Biomed; 1998 May; 56(2):157-64. PubMed ID: 9700430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DIAS-NIDDM--a model-based decision support system for insulin dose adjustment in insulin-treated subjects with NIDDM.
    Tudor RS; Hovorka R; Cavan DA; Meeking D; Hejlesen OK; Andreassen S
    Comput Methods Programs Biomed; 1998 May; 56(2):175-91. PubMed ID: 9700432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DIAS--the diabetes advisory system: an outline of the system and the evaluation results obtained so far.
    Hejlesen OK; Andreassen S; Hovorka R; Cavan DA
    Comput Methods Programs Biomed; 1997 Sep; 54(1-2):49-58. PubMed ID: 9290919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a double blind controlled clinical trial to evaluate the function of a Diabetes Advisory System: a feasible approach?
    Hejlesen OK; Andreassen S; Frandsen NE; Sørensen TB; Sandø SH; Hovorka R; Cavan DA
    Comput Methods Programs Biomed; 1998 May; 56(2):165-73. PubMed ID: 9700431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the DIAS model to predict unrecognised hypoglycaemia in patients with insulin-dependent diabetes.
    Cavan DA; Hovorka R; Hejlesen OK; Andreassen S; Sönksen PH
    Comput Methods Programs Biomed; 1996 Aug; 50(3):241-6. PubMed ID: 8894383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired absorption and omission of insulin: a novel method of detection using the diabetes advisory system computer model.
    Turner BC; Hejlesen OK; Kerr D; Cavan DA
    Diabetes Technol Ther; 2001; 3(1):99-109. PubMed ID: 11469714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
    Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence for a high incidence of nocturnal hypoglycaemia in IDDM: no effect of dose for dose transfer between human and porcine insulins.
    George E; Bedford C; Peacey SR; Hardisty CA; Heller SR
    Diabet Med; 1997 Jun; 14(6):442-8. PubMed ID: 9212308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model-based blood glucose control for Type 1 diabetes via parametric programming.
    Dua P; Doyle FJ; Pistikopoulos EN
    IEEE Trans Biomed Eng; 2006 Aug; 53(8):1478-91. PubMed ID: 16916082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.
    Kovatchev B; Cheng P; Anderson SM; Pinsker JE; Boscari F; Buckingham BA; Doyle FJ; Hood KK; Brown SA; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Ly TT; Shanmugham S; Dassau E; Kollman C; Lum JW; Beck RW
    Diabetes Technol Ther; 2017 Jan; 19(1):18-24. PubMed ID: 27982707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial rather than preprandial glucose levels should be used for adjustment of rapid-acting insulins.
    Bell DS; Ovalle F; Shadmany S
    Endocr Pract; 2000; 6(6):477-8. PubMed ID: 11155223
    [No Abstract]   [Full Text] [Related]  

  • 12. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
    Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
    Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A neural network approach for insulin regime and dose adjustment in type 1 diabetes.
    Mougiakakou SG; Nikita KS
    Diabetes Technol Ther; 2000; 2(3):381-9. PubMed ID: 11467341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
    Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin dosage adjustment in diabetes.
    Lehmann ED; Deutsch T
    J Biomed Eng; 1992 May; 14(3):243-9. PubMed ID: 1588782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose response to intense aerobic exercise in type 1 diabetes: maintenance of near euglycemia despite a drastic decrease in insulin dose.
    Mauvais-Jarvis F; Sobngwi E; Porcher R; Garnier JP; Vexiau P; Duvallet A; Gautier JF
    Diabetes Care; 2003 Apr; 26(4):1316-7. PubMed ID: 12663620
    [No Abstract]   [Full Text] [Related]  

  • 18. Type 1 diabetes mellitus in a routine diabetes clinic: the association of psycho-social factors, diabetes knowledge and glycaemic control to insulin regime.
    Pawar BK; Walford S; Singh BM
    Diabetes Res Clin Pract; 1999 Nov; 46(2):121-6. PubMed ID: 10724090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDA2: a Mk. II automated insulin dosage advisor.
    Lehmann ED; Deutsch T
    J Biomed Eng; 1993 May; 15(3):201-11. PubMed ID: 8320979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.